Health Law Daily Wrap Up, DRUGS AND BIOLOGICS—NOTICES: Regulatory framework for deceased donor islet cell therapies for type I diabetes, (Sep 25, 2026)
Organizations Mentioned:National Institutes of Health
By WK Editorial Staff
Various agencies are requesting information on whether publicly available evidence could support standardized regulation of deceased donor islet cell therapies and whether unmodified deceased donor islet cells should be regulated as organs under the ...